Sign In
Buy WLKP
Westlake Chemical Partners LP Earnings Calls
| Release date | Oct 30, 2025 |
| EPS estimate | $0.430 |
| EPS actual | $0.420 |
| EPS Surprise | -2.33% |
| Revenue estimate | 303M |
| Revenue actual | 308.898M |
| Revenue Surprise | 1.95% |
| Release date | Aug 05, 2025 |
| EPS estimate | $0.444 |
| EPS actual | $0.410 |
| EPS Surprise | -7.72% |
| Revenue estimate | 301M |
| Revenue actual | 297.119M |
| Revenue Surprise | -1.29% |
| Release date | May 02, 2025 |
| EPS estimate | $0.380 |
| EPS actual | $0.140 |
| EPS Surprise | -63.16% |
| Revenue estimate | 296M |
| Revenue actual | 237.629M |
| Revenue Surprise | -19.72% |
| Release date | Feb 24, 2025 |
| EPS estimate | $0.360 |
| EPS actual | $0.430 |
| EPS Surprise | 19.44% |
| Revenue estimate | 262M |
| Revenue actual | 290.06M |
| Revenue Surprise | 10.71% |
Last 4 Quarters for Westlake Chemical Partners LP
Below you can see how WLKP performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 24, 2025 |
| Price on release | $24.42 |
| EPS estimate | $0.360 |
| EPS actual | $0.430 |
| EPS surprise | 19.44% |
| Date | Price |
|---|---|
| Feb 18, 2025 | $23.91 |
| Feb 19, 2025 | $24.18 |
| Feb 20, 2025 | $24.14 |
| Feb 21, 2025 | $24.22 |
| Feb 24, 2025 | $24.42 |
| Feb 25, 2025 | $24.20 |
| Feb 26, 2025 | $24.05 |
| Feb 27, 2025 | $23.97 |
| Feb 28, 2025 | $24.00 |
| 4 days before | 2.13% |
| 4 days after | -1.72% |
| On release day | -0.90% |
| Change in period | 0.376% |
| Release date | May 02, 2025 |
| Price on release | $23.27 |
| EPS estimate | $0.380 |
| EPS actual | $0.140 |
| EPS surprise | -63.16% |
| Date | Price |
|---|---|
| Apr 28, 2025 | $23.66 |
| Apr 29, 2025 | $23.77 |
| Apr 30, 2025 | $23.39 |
| May 01, 2025 | $23.80 |
| May 02, 2025 | $23.27 |
| May 05, 2025 | $23.16 |
| May 06, 2025 | $23.01 |
| May 07, 2025 | $23.06 |
| May 08, 2025 | $23.20 |
| 4 days before | -1.65% |
| 4 days after | -0.301% |
| On release day | -0.473% |
| Change in period | -1.94% |
| Release date | Aug 05, 2025 |
| Price on release | $22.01 |
| EPS estimate | $0.444 |
| EPS actual | $0.410 |
| EPS surprise | -7.72% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $21.96 |
| Jul 31, 2025 | $22.03 |
| Aug 01, 2025 | $21.82 |
| Aug 04, 2025 | $21.80 |
| Aug 05, 2025 | $22.01 |
| Aug 06, 2025 | $21.92 |
| Aug 07, 2025 | $21.96 |
| Aug 08, 2025 | $21.95 |
| Aug 11, 2025 | $22.32 |
| 4 days before | 0.228% |
| 4 days after | 1.41% |
| On release day | -0.409% |
| Change in period | 1.64% |
| Release date | Oct 30, 2025 |
| Price on release | $18.95 |
| EPS estimate | $0.430 |
| EPS actual | $0.420 |
| EPS surprise | -2.33% |
| Date | Price |
|---|---|
| Oct 24, 2025 | $19.87 |
| Oct 27, 2025 | $19.63 |
| Oct 28, 2025 | $19.31 |
| Oct 29, 2025 | $18.95 |
| Oct 30, 2025 | $18.95 |
| Oct 31, 2025 | $18.86 |
| Nov 03, 2025 | $18.67 |
| Nov 04, 2025 | $18.50 |
| Nov 05, 2025 | $18.66 |
| 4 days before | -4.63% |
| 4 days after | -1.53% |
| On release day | -0.475% |
| Change in period | -6.09% |
Westlake Chemical Partners LP Earnings Call Transcript Summary of Q3 2025
Westlake Chemical Partners reported third quarter 2025 results with Partnership net income of $15 million ($0.42/unit) and distributable cash flow of $15 million ($0.42/unit). Consolidated net income (including OpCo) was $86 million on consolidated net sales of $309 million. Results benefited from the completion of the planned Petro 1 ethylene turnaround in Lake Charles. Distributable cash flow declined versus Q3 2024 primarily due to higher maintenance capex and timing of maintenance activities. The Partnership announced a quarterly distribution of $0.4714/unit to be paid November 26, 2025 (record date Nov 10). Westlake Partners maintains conservative leverage (consolidated leverage ~1x) and had $51 million in cash/investments with Westlake at quarter end; long-term debt was $400 million. OpCo spent $30 million on capex in the quarter. Management renewed the Ethylene Sales Agreement with parent Westlake through end of 2027 with no changes to terms, preserving the fixed-margin, take-or-pay structure that supports roughly 95% of OpCo production and the Partnership's fee-based cash flow. They have no planned turnarounds for the remainder of 2025 or in 2026 and reiterated four growth levers: increase OpCo ownership, acquisitions of income streams, organic expansions, and negotiating higher fixed margin with Westlake. Management expects the completed turnaround and operating surplus to restore distribution coverage.
